Instrument Inactif

Communiqués Bavarian Nordic A/S CBOE EUROPE EQUITIES

Actions

DK0015998017

Cours en clôture CBOE EUROPE EQUITIES Autres places de cotation
- ^DKK	-

01/07	Bavarian Nordic transforme sa facilité de 1 milliard de couronnes danoises en un prêt lié au développement durable	MT
28/06	Bavarian Nordic fait don d'un vaccin contre la variole pour lutter contre l'épidémie en Afrique	MT

Communiqués

Débloquez toutes les actualités : Soyez le premier informé et réagissez avant les marchés !

Inscription 100% Gratuite

Bavarian Nordic Converts Existing Credit Facility into Sustainability-linked Loan	01/07	GL
Bavarian Nordic Joins Global Efforts to Fight Mpox Outbreak in Africa	28/06	GL
Bavarian Nordic Submits Marketing Authorization Application for its Chikungunya Vaccine Candidate to EMA	26/06	GL
Bavarian Nordic Completes BLA Submission to U.S. FDA for its Chikungunya Vaccine Candidate	17/06	GL
Bavarian Nordic Submits Supplemental BLA Seeking U.S. FDA Approval of Freeze-Dried Formulation of Smallpox and Mpox Vaccine	31/05	GL
Bavarian Nordic and CEPI Partners to Advance Mpox Vaccination in Africa	30/05	GL
Capital Increase in Bavarian Nordic A/S as a Result of Employee Warrant Exercise	22/05	GL
Bavarian Nordic A/S : Transactions in Connection with Share Buy Back Program and Termination of Share Buy Back Program	21/05	PU
Bavarian Nordic – Transactions in Connection with Share Buy-Back Program and Termination of Share Buy-Back Program	21/05	GL
EVP and Chief Medical Officer Laurence de Moerlooze Will Be Leaving Bavarian Nordic	21/05	GL
Bavarian Nordic Launches Share Buy-Back Program to Hedge Incentive Scheme Obligations	08/05	GL
Bavarian Nordic A/S : Interim Results (Q1) as of 31 March 2024	08/05	PU
Bavarian Nordic Announces Interim Results for the First Three Months of 2024	08/05	GL
Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such	07/05	GL
Bavarian Nordic Receives 65 mEUR Contract to Supply Smallpox Vaccines for EU Strategic Reserve	29/04	GL
Bavarian Nordic Initiates Rolling Submission of Biologics License Application with FDA for its Chikungunya Vaccine Candidate	29/04	GL
ExpreS2ion to receive approximately SEK 22.5 million dividend payment from AdaptVac ApS	23/04	AQ
Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such	22/04	GL
Resolutions of the Annual General Meeting 2024 of Bavarian Nordic A/S	16/04	GL
Morris & Dickson is the First U.S. Distributor for Bavarian Nordic's JYNNEOS, the Only FDA-approved Mpox Vaccine	04/04	AQ

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Communiqués Bavarian Nordic A/S CBOE EUROPE EQUITIES

Actions

DK0015998017

Communiqués

Filtres